Previous close | 396.28 |
Open | 399.60 |
Bid | 378.40 x 800 |
Ask | 389.13 x 900 |
Day's range | 390.79 - 401.27 |
52-week range | 240.54 - 403.00 |
Volume | |
Avg. volume | 1,672,280 |
Market cap | 139.164B |
Beta (5Y monthly) | 1.36 |
PE ratio (TTM) | 78.06 |
EPS (TTM) | 5.03 |
Earnings date | 16 Apr 2024 - 22 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 410.80 |
Recently, Zacks.com users have been paying close attention to Intuitive Surgical, Inc. (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical stock yo-yoed, but closed in the green, Friday after the FDA cleared its new robotic surgery system, da Vinci 5.
Intuitive Surgical (ISRG) announces the FDA clearance for its next-generation robotic system, da Vinci 5, which is likely to improve surgical workflow and save significant time with better care.